The University of Toronto Faculty of Medicine will benefit from a $250 million donation to support advances in human health and health care; Roger Scott-Douglas is the acting new president of the National Research Council of Canada.
Topic: antibody therapeutics
Brain Canada & CQDM fund AbCellera’s cell screening platform technology
AbCellera Biologics Inc and the Univ of British Columbia (UBC) received non-dilutive funding of $1 million from pharma-based consortium CQDM and charitable organization Brain Canada Foundation to advance a discovery platform for next-generation antibody therapeutics. With the additional contribution of $450,000 from AbCellera, the program will leverage AbCellera’s high throughput, single-cell screening platform to allow rapid…